American Association for the Advancement of Science, Science Translational Medicine, 526(12), 2020
DOI: 10.1126/scitranslmed.aay6931
Export citation
Search in Google Scholar
Show less
Full text: Unavailable
Noradrenergic signaling sensitizes pathological GSK3β/tau activation to nanomolar Aβ.